Carmen Rodríguez‐Cueto

Targeting glial cannabinoid <scp>CB₂</scp> receptors to delay the progression of the pathological phenotype in <scp>TDP‐43</scp> (<scp>A315T</scp>) transgenic mice, a model of amyotrophic lateral sclerosis

Francisco Espejo‐Porras, Laura García‐Toscano, Carmen Rodríguez‐Cueto et al. · British Journal of Pharmacology · 2018 · 80 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Changes in <scp>CB₁</scp> and <scp>CB₂</scp> receptors in the post‐mortem cerebellum of humans affected by spinocerebellar ataxias

Carmen Rodríguez‐Cueto, Cristina Benito, Javier Fernández‐Ruíz et al. · British Journal of Pharmacology · 2013 · 68 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment

Loreto Martínez‐González, Carmen Rodríguez‐Cueto, Diego Cabezudo et al. · Scientific Reports · 2020 · 67 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Up-regulation of CB2 receptors in reactive astrocytes in canine degenerative myelopathy, a disease model of amyotrophic lateral sclerosis

María Fernández-Trapero, Francisco Espejo‐Porras, Carmen Rodríguez‐Cueto et al. · Disease Models & Mechanisms · 2017 · 65 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1G93A transgenic mice, an experimental model of amyotrophic lateral sclerosis

Carmen Rodríguez‐Cueto, Irene Santos‐García, Laura García‐Toscano et al. · Biochemical Pharmacology · 2018 · 61 citations

Life Sciences, Neurobiology, Neuroscience +16